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ABSTRACT 
Instrumented multilevel spine surgery is associated with a large amount of opioid 
consumption, difficult mobilization, and significant pain in a population of patients who 
are predominantly already chronic pain sufferers (Mathiesen et al., 2013). The Health 
Resources and Services Administration (2018) recently claimed that our nation is in the 
midst of an opioid epidemic, with more than 115 opioid-related deaths occurring every 
year.  As a result of this epidemic, many anesthesia providers have become aware and are 
attempting to do something about it. Organizations such as the Society for Opioid Free 
Anesthesia are at the forefront of the battle against the opioid crisis, promoting alternative 
drug therapy for pain control during and following surgery. This response has been an 
effort to not only prevent chronic pain but ultimately, to limit our population’s worsening 
dependence on opioids. One of the most common alternatives to opioids being used is 
dexmedetomidine. This project, inspired by the current crisis, involved the creation of a 
policy that details the use of intraoperative dexmedetomidine on patients undergoing 
instrumented spinal surgery. Collaboration with a physician anesthesiologist and an 
evidence review guided the development of the policy. Following completion, the policy 
was present to a panel of experts, which consisted of anesthesia providers who routinely 
take part in spinal surgery cases.  Feedback was taken from the panel using a survey tool. 
Results of the survey revealed that the experts were willing to consider changing their 
practices to include dexmedetomidine as part of their anesthetic care.
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CHAPTER I - INTRODUCTION 
From 1999 to 2014, prescription opioid sales nearly quadrupled in the United 
States. In the same period, no overall change in reported pain was reported (Centers for 
Disease Control and Prevention [CDC], 2017). The number of opioid overdose deaths has 
increased at a similar rate as the number of opioid prescriptions (CDC, 2017). It is 
estimated that 1 in 5 patients with pain-related and non-cancer diagnoses is prescribed 
opioids (CDC, 2017). The number of prescriptions has increased the most among 
specialists, with surgery prescribing rates among the highest at 37% (CDC, 2017). 
Greater than 115 Americans die every day from an opioid overdose, with nearly half of 
those deaths involving a prescription opioid (Mississippi State Department of Health 
[MSDH], 2018). The highest ratio of prescriptions per person in the country is found in 
the southern states, including Mississippi where opioid involved overdose deaths have 
doubled since the year 2000 (MSDH, 2018). Patients undergoing spinal surgery are likely 
receiving prescriptions for opioids prior to having the procedure. In addition, pain is a 
common and an expected outcome in patients undergoing these procedures due to the 
unavoidable tissue damage that occurs during instrumented spinal surgery (Devin & 
McGirt, 2015). Opioids are commonly continued postoperatively following spinal 
surgery, typically, the first-line agent in post-operative pain management (Devin & 
McGirt, 2015). The overuse of opioids has been “associated with significant adverse side 
effects including somnolence, confusion, urinary retention, ileus, respiratory depression, 
and death” (Devin & McGirt, 2015, p. 931). Post-operative pain manifests through 
multiple neurophysiological and chemical pathways. Additionally, sensitization 
peripherally and centrally further contributes to the occurrence of hyperalgesia, which 
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results in increased pain. Due to this, multimodal approaches to pain management have 
become prevalent among anesthesia providers, targeting multiple pain signaling pathways 
to improve pain management, while minimizing adverse effects (Devin & McGirt, 2015). 
Due to the alarming increase in opioid prescriptions and overdoses involving opioids, it is 
important that anesthesia providers be aware of the epidemic and up to date on the most 
recent recommendations for multimodal pain management. 
Background and Significance 
Instrumented multilevel spine surgery is associated with a large amount of opioid 
consumption, difficult mobilization, and significant pain in a population of patients who 
are predominantly already chronic pain sufferers (Mathiesen et al., 2013). Over the last 
10 years, the number of patients having spinal surgery has seen an increase (Mathiesen et 
al., 2013). Spinal procedures are associated with intense postoperative pain, especially in 
the immediate days following surgery. A considerable degree of pain is common due to 
the extensive dissection of tissues, ligaments, and bones. The pain resulting from these 
surgeries is typically severe and lasts for approximately three days. Complicating the 
postoperative pain management picture is the fact that most of these patients are already 
being treated with traditional narcotics or analgesics preoperatively. Postoperative pain 
results from activation of varying mechanisms, including neuropathic, nociceptive, and 
inflammatory pathways (Mathiesen et al., 2013). A balanced approach to postoperative 
pain management that targets multiple pain pathways is a logical course of action 
(Mathiesen et al., 2013). Dexmedetomidine is a highly selective alpha 2 adrenoceptor 
agonist, with analgesic and sedative properties, that is being increasingly used as an 
adjunct to multimodal pain management strategies (Ramsay & Luterman, 2004). 
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Problem Statement 
The use of opioids is an essential element of pain management perioperatively, 
however, their detrimental side effects are well known and feared among anesthesia 
providers. The escalating use of prescription opioids over the last 20 years has caused 
their clinical utilization to become a public health concern. Many practitioners and 
policymakers have called for a reduction in the number of prescriptions as they aim to 
reconcile the commitment to deliver effective control of pain, with the circumvention of 
opioid-related side effects. Trending increases in spinal surgical volume will more than 
likely potentiate the problem. The emergence of dexmedetomidine as an effective agent 
for providing analgesia post spinal surgery has given anesthesia providers another adjunct 
to use for multimodal pain management. The decision to use opioid alternatives, such as 
dexmedetomidine, is solely in the hands of the individual provider. The development of 
an intraoperative dexmedetomidine policy may help create a standard, increase its 
utilization, decrease postoperative pain, and prevent further contribution to the current 
opioid epidemic (Cozowicz et al., 2017). 
Purpose of the Project 
The purpose of this project was to construct a policy for the use of 
dexmedetomidine intraoperatively in spinal surgery in an effort to reduce postoperative 
pain and opioid usage. The policy was written for an orthopedic specialty hospital in 
southeast Mississippi and was designed to be a point of reference for the providers who 
practice there. Specific instructions were included related to appropriate dosage, timing 
of administration, and patient exclusion criteria founded on the most recent evidence-
based research and best practice recommendations. The goal of the policy was to educate 
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the providers and present guidelines that would allow for the safe and effective 
administration of dexmedetomidine, as a supplement to multimodal pain management.  
Needs Assessment 
In order to determine the providers’ knowledge base and competency concerning 
proper dexmedetomidine administration during spinal surgery, a needs assessment was 
performed. Many providers feel that the time it takes to prepare the infusion makes it an 
unfeasible option, while others were unaware of the analgesic properties of 
dexmedetomidine. Many providers do not have a firm understanding of the most 
effective dosage and timing of administration, while others do not have adequate 
knowledge regarding patient inclusion and exclusion criteria. Having a policy 
implemented will allow for guidance, instruction, and education that will lead to an 
increase in the use and effectiveness of dexmedetomidine. The policy is being written at 
the request of the medical director at the Orthopedic Institute (OI), a specialty orthopedic 
surgery center in Hattiesburg, MS. 
Conceptual Framework 
The conceptual framework used for this project was Friedman’s Policy 
Development Framework. Friedman (2003) presented a framework for the development 
of policy and implementation, based on a review of the evidence. The framework focuses 
on four dimensions: 
1. The stages of policy development and implementation 
2. The levels at which policy is developed and the interrelationships among the 
levels 
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3. The service sectors or systems affected by policy and the interrelationships 
among policy in different sectors 
4. The variables that are likely to affect the level of impact of a policy 
(Friedman, 2003, p. 12) 
The Stages of Policy Development and Implementation 
Five stages can be identified in policy development and implementation. 
Identification of a problem needing to be addressed is the first stage. The second stage, 
policy development, follows the problem identification. After the new policy is 
established, the third stage is the implementation of the statute. Evaluation of the impact 
of the policy and the effect of its implementation is the fourth stage. Finally, the fifth 
stage is a modification of the policy with or without modification of the implementation 
approach (Friedman, 2003). 
The Levels at Which Policy is Developed and the Interrelationships among the Levels 
Policies are often established at different levels. The most crucial aspect, 
however, may not be the specific level that establishes the policy, but the relationships 
between the different levels in the implementation. The relationships play a vital role in 
the final impact of the policy (Friedman, 2003). 
The Service Sectors or Systems Affected by Policy and the Interrelationships among 
Policy in Different Sectors 
The previous dimension deals with groups on different levels, or vertical issues. 
An example of a vertical issue is the relationship between hospital administration and a 
hired anesthesia group. This dimension applies to more horizontal relationships or entities 
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on the same level. Such relationships would include those between a hospital’s pharmacy 
and the operating room (Friedman, 2003). 
The Variables That Are Likely to Affect the Level of Impact of a Policy 
This dimension deals with describing variables that are thought to be related to 
the policy’s success in achieving its goals. A policy’s effectiveness in achieving its 
intended outcome is dependent on three different variable types: “(a) those related to the 
nature of the problem that the policy addresses; (b) those related to the policy itself and 
its implementation; and (c) those that although not related to the policy, affect its 
implementation nonetheless” (Friedman, 2003, p. 13). Positive results will more likely 
occur in situations where a clear understanding of the necessary changes to solve the 
problem is present, the desired behavior to be regulated is unvaried, the problem does not 
involve a large subset of people, and the amount of change required is minimal 
(Friedman, 2003). 
DNP Essentials 
The American Association of the Colleges of Nursing (AACN, 2006) have 
provided eight essential components required for completion of a Doctorate of Nursing 
Practice (DNP). These eight essentials are foundational competencies and are a 
requirement of all DNP graduates in all specialties. This project has addressed each 
essential and is outlined below. 
DNP Essential I: Scientific Underpinnings for Practice 
Knowledge of the sciences was used to translate research findings into a policy 
for the use of dexmedetomidine intraoperatively. This policy was an example of 
development and evaluation of new practice approaches that were theory based in 
 7 
nursing. The significance, as well as the nature of the problem, was determined. Actions 
and advanced strategies to enhance the use of dexmedetomidine was described in the 
policy and outcomes were evaluated (AACN, 2006). 
DNP Essential II: Organizational and Systems Leadership for Quality Improvement and 
Systems Thinking 
The organizational and systems leadership requirement was met by improving the 
safety of patients receiving dexmedetomidine intraoperatively, through the use of policy 
writing. The need for a multimodal approach to pain management in the population of 
patients undergoing spinal surgery was assessed based on scientific, organizational, 
political, and economic sciences. The policy, in a sense, was a method of communication 
that could potentially lead to an improvement in quality and patient safety within the 
facility for which it is developed (AACN, 2006). 
DNP Essential III: Clinical Scholarship and Analytical Methods for Evidence-Based 
Practice 
Prior to the development of the policy, analytical methods were used to critically 
appraise the existing evidence, to determine the best evidence for practice. Information 
technology was utilized, and research methods applied to collect the appropriate data to 
formulate the policy. Data were analyzed, and patterns of outcomes and behavior were 
examined to identify gaps in the evidence and construct the policy (AACN, 2006).  
DNP Essential IV: Information Systems/Technology and Patient Care Technology for the 
Improvement and Transformation of Health Care 
The policy development and intervention for this project were created using 
information systems/technology. The policy was designed to support the healthcare 
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system it was developed for and improve patient care. Technical skills and conceptual 
ability was demonstrated to develop the evaluation plan following policy development 
(AACN, 2006).   
DNP Essential V: Health Care Policy for Advocacy in Health Care 
The fifth essential was met through institutional decision making if they chose to 
accept the policy. Organizational standards created a framework to facilitate the delivery 
of dexmedetomidine. “The engagement in the process of policy development is central to 
creating a healthcare system that meets the needs of its constituents” (AACN, 2006, p. 
13). The policy was designed to influence, regulate the practice, improve safety, enhance 
quality, and ameliorate the efficacy of providers (AACN, 2006).  
DNP Essential VI: Interprofessional Collaboration for Improving Patient and Population 
Health Outcomes 
The development of the policy was executed through collaboration with the 
physician anesthesiologist and medical director of the facility, the facility’s stakeholders, 
as well as nurse anesthesia program faculty from The University of Southern Mississippi 
(USM). Interprofessional collaboration was employed to improve health outcomes. The 
development of the policy using collaboration fulfilled the requirement of essential seven 
(AACN, 2006). 
DNP Essential VII: Clinical Prevention and Population Health for Improving the 
Nation’s Health 
One of the goals of developing the dexmedetomidine policy was a reduction in 
the requirement of opioids intraoperatively and, secondarily, a reduction in the number of 
patients being discharged home with opioid prescriptions. This implementation can be a 
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small step in the right direction of resolving our nation’s opioid crisis. The more policies 
developed that have the potential to reduce narcotic consumption, the faster the trending 
rise in usage can be reversed (AACN, 2006).  
DNP Essential VIII: Advanced Nursing Practice 
The eighth and final essential was met through the design, implementation, and 
evaluation of the policy as an intervention based on nursing sciences. The policy 
demonstrated an advanced level of clinical judgment, accountability in design, delivery, 
and systems thinking. Evaluation of evidence-based treatments and dexmedetomidine 
research was utilized to improve patient outcomes (AACN, 2006). 
Review of Evidence 
An extensive literature review was performed to examine all current evidence of 
dexmedetomidine’s use as an analgesic agent. Databases used included CINAHL with 
Full-Text, PubMed, MEDLINE, Google Scholar, and Cochrane Library. Terms used in 
the search included: dexmedetomidine, dexmedetomidine spine surgery, spine surgery, 
perioperative pain, dexmedetomidine pain, multimodal analgesia, opioid sparing, 
postoperative pain, opioid spine surgery, and policy. Filtering criteria limited searches to 
full text only with publication dates between 2008 and 2018, which resulted in 105 full-
text articles after accounting for duplications. After reviewing all articles, 19 were chosen 
for the inclusion of the project due to their applicability to the topic. 
Multimodal Pain Management for Spinal Surgery 
Surgical procedures on the spine are typically associated with severe pain in the 
postoperative period, especially in the first few days (Bajwa & Haldar, 2015). Pain 
management after spine surgery has historically relied on the heavy usage of opioid 
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medications (Kurd, Kreitz, Schroeder, & Vaccaro, 2017). Multimodal strategies of pain 
control were designed to minimize opioid consumption and the adverse effects associated 
with their use (Kurd et al., 2017). A growing amount of evidence supports the use of a 
multimodal technique to pain management during spine surgery (Kurd et al., 2017). 
Providing patients with adequate postoperative pain control enables for faster 
rehabilitation, improved mobility, and improved patient satisfaction scores (Kurd et al., 
2017). Adequate postoperative pain management has also been shown to prevent the 
development of chronic pain (Bajwa & Haldar, 2015). Alpha 2 agonists, such as 
clonidine and dexmedetomidine have proven to be effective agents to provide analgesia 
in spinal surgery (Bajwa & Haldar, 2015). The lack of respiratory depression and their 
hemodynamic stability are added benefits of these drugs (Bajwa & Haldar, 2015). Bidyut 
and Amutha (2012) found dexmedetomidine to be an ideal anesthetic adjuvant in patients 
undergoing cervical spine surgery. In these patients, dexmedetomidine provided 
decreases in anesthetic requirements, a reduction in intubation response, improvements in 
analgesia, and avoided significant respiratory and hemodynamic compromise (Bidyut & 
Amutha, 2012). 
Sparing Effect of Dexmedetomidine and Recovery 
“Dexmedetomidine presumably acts on the nociceptive cascade and prevents the 
sensitization of nociceptors present in the dorsal horn” (Bajwa & Haldar, 2015, p. 109). 
Dexmedetomidine has a high affinity and selectivity and aids in the decrease of opioid 
and local anesthetic dosages, therefore, reducing the risk of the adverse effects of these 
medications when they are used simultaneously with dexmedetomidine (Bajwa & Haldar, 
2015). Intraoperative dexmedetomidine has been shown to reduce anesthetic 
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requirements and lead to early tracheal extubation postoperatively (Afanador et al., 
2009). Dexmedetomidine is capable of attenuating various stress responses and is able to 
maintain hemodynamic stability during surgery when used as an adjuvant during general 
anesthesia (Patel, Engineer, Shah, & Madhu, 2012). Additionally, dexmedetomidine 
administered intraoperatively appears to enhance the analgesic property of morphine-
based patient-controlled analgesia (PCA) in spinal surgery patients postoperatively (Ge, 
Qi, Tang, & Li, 2015). 
Reduction of Postoperative Side Effects 
In addition to providing improvements in analgesia and reductions in narcotic 
requirements, dexmedetomidine has been shown to limit postoperative side effects of 
anesthesia (Bakri, Ismail, & Ibrahim, 2015). “Dexmedetomidine has an effect similar to 
that of dexamethasone in reducing the incidence and severity of postoperative nausea and 
vomiting (PONV)” (Bakri et al., 2015, p. 259). A recent meta-analysis by Wang et al. 
(2016) concluded that dexmedetomidine given perioperatively decreased the incidence of 
shivering and postoperative nausea in laparoscopic surgery patients. Another study by 
Choi et al. (2017) found similar results, stating that “adjuvant use of intraoperative 
dexmedetomidine infusion may be effective for the prevention of PONV” (p. 1). 
Dexmedetomidine Dosage 
The use of dexmedetomidine intraoperatively is well established to improve pain 
control postoperatively, with or without a loading dose (Fan et al., 2017). In a study 
comparing the use of dexmedetomidine with and without a loading dose, Fan et al. (2017) 
found that the administration of a loading dose did not affect the analgesic effect. A 
review conducted by Ickeringill, Shehabi, Adamson, and Reuttimann (2004) determined 
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that undesirable hemodynamic effects could be avoided without compromising analgesia 
by omitting a loading dose. Tiwari (2014) compared two different doses of 
dexmedetomidine and their effects on postoperative pain and sedation. Patients were 
divided randomly into three groups—a control group (saline infusion), a low dose 
dexmedetomidine infusion group (0.3 mcg/kg/hr), and a high dose dexmedetomidine 
infusion group (0.6 mcg/kg/hr) (Tiwari, 2014). The usage of fentanyl, duration of 
infusion, and duration of surgery was determined to be statistically insignificant in all 
three groups (Tiwari, 2014). Pain scores in both dexmedetomidine groups were 
significantly lower than the control group in the period immediately after surgery through 
six hours post-surgery (Tiwari, 2014). Tiwari (2014) concluded that both dosages of 
dexmedetomidine provided similar improvements in postoperative pain control. The 
recommended dose range of dexmedetomidine is 0.2 to 0.7 mcg/kg/hr for no longer than 
24 hours (Kim, 2014). 
Summary 
The significant pain associated with spinal surgery and the increasing reliance on 
opioids are representative of the background and significance of this project. 
Development of intraoperative dexmedetomidine policies may allow for a reduction in 
narcotic usage. The purpose of the project was to construct such a policy that would 
outline the use of dexmedetomidine during multilevel instrumented spinal surgery. A 
needs assessment was performed to determine the current knowledge base of the 
anesthesia providers at the OI. The review of the evidence presented dexmedetomidine as 
a useful adjunct to multimodal pain management and provided insight on optimal dosage 
and timing. Dexmedetomidine was shown to have a sparing effect on narcotics, enhance 
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recovery, and reduce postoperative side effects. The theoretical framework outlined 
above was chosen because it was based on evidence and focused on policy development 
and implementation. Eight DNP essentials required by the AACN have been addressed 
by completion of this project. 
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CHAPTER II – METHODOLOGY 
Population 
This project targeted two populations of interest. The primary population was 
patients undergoing multilevel instrumented spine surgery. A second population was the 
anesthesia providers at the OI, a specialty orthopedic surgery center in Hattiesburg, 
Mississippi.  
Target Outcome 
The expected outcome of my project was to create a policy that would provide 
stakeholders at the OI a thorough evidence-based policy. A thorough evidence-based 
policy would offer the opportunity for a change in the practice of the anesthesia providers 
at the OI if they chose to implement it. The goal was for the policy to provide a resource 
that was easily referenced when required and provide a pathway to increase the use of 
dexmedetomidine during spinal surgery. Increased dexmedetomidine use can potentially 
improve pain control and may lead to a decrease in postoperative pain and perioperative 
opioid use.  
Design 
In collaboration with a physician anesthesiologist and medical director of the OI, 
an evidence-based policy was developed and submitted for implementation in an effort to 
increase the routine use of intraoperative dexmedetomidine infusions during spinal 
surgeries. The policy contained information regarding dosage and timing of 
administration, exclusion criteria for specific patient populations, and guidelines for 
administration. Once completed, the policy was presented to an expert panel including 
anesthesia providers, hospital administrators, DNP, and Certified Registered Nurse 
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Anesthesia (CRNA) faculty at USM. Input was received, and the survey completed. The 
survey was given to the expert panel and contained questions such as: “How would you 
make the policy more user-friendly?”, “What would you add to make the policy better?”, 
and “What would you add or remove to make the policy clearer or more concise?” Data 
from the results of the surveys were collected and analyzed. The finalized policy was 
presented to the DNP project committee members and again to the panel of experts. 
Lastly, recommendations and the completed policy were submitted via email in pdf 
format to the medical director of the OI for his consideration to implement the policy. 
Barriers 
It was important to be prepared for challenges that were possible during the 
project implementation. Although outside the scope of this project, one potential barrier 
to the acceptance of an institutional policy was resistance to change on the part of the 
members of the institution. If pushback was received from the providers of the OI, 
progress may have been slowed. Consultation with a collaborating physician and director 
of the OI would hopefully alleviate any hesitancy from the anesthesia staff. Other 
potential barriers included the increased cost to add the drug to the formulary of the 
pharmacy, as well as adequately educating the recovery nurses on the proper care of 
patients receiving dexmedetomidine intraoperatively. The director of the OI agreed to 
discuss and negotiate these requirements with the pharmacy as needed. 
Ethical Considerations 
The Institutional Review Board (IRB) at USM approved this project prior to 
creation, presentation, and implementation of the policy (Protocol #18071906). No 
human subjects were being studied; therefore, IRB approval from the OI was not 
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necessary. Any participation in this project was completely voluntary. At the patient 
level, a few ethical situations were considered. Inequality of care was an important 
ethical issue to consider in the process of developing the policy for this project. An 
example of inequality of care would be if one provider used dexmedetomidine for a 
patient, while another provider chose not to use the drug on another patient undergoing 
the same procedure. Another consideration was the issue of an uninsured patient not 
having the ability to pay for the drug or an insured patient whose insurance company 
denied payment. An adequate policy would assist to prevent unethical situations from 
arising in anesthetic planning and the care of patients.  
Components of a Quality Policy 
 Policies are written to address an institution or organization’s specific need. The 
components and structure of a policy will vary according to the need; some being several 
pages, while others may be a single page. The organization, Sport and Recreation 
Victoria, suggests that a quality policy has nine components. The first component is a 
goal statement of what the organization would like to achieve. The goal for this project 
was for the policy to provide a resource that was easily referenced when required and 
provide a pathway to increase the use of dexmedetomidine during spinal surgery. 
Improvement in pain control could lead to a decrease in postoperative pain and 
perioperative opioid use. The second component is that the policy is founded on 
principles, values, and philosophies. The policy for the OI was founded on evidence-
based research. The third objective is that the policy should contain broad objectives that 
clearly define what areas the organization is involved in. The policy clearly stated for 
dexmedetomidine to be used intraoperatively, which met the objective. Objective four 
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states that there should be strategies included to achieve each objective. Specific actions 
to be taken should be included in the policy, which is objective five. Objective six states 
that a policy should include desired outcomes of the specific actions. When constructing 
the policy, detailed instructions and strategies, along with desired outcomes were 
provided to ensure objectives four, five, and six were met. The seventh objective is for 
the policy to include performance indicators that the policy can be effectively measured 
by. Management plans are included as the eighth objective and provide further detail on 
the policy’s implementation and observation on a daily basis. Objectives seven and eight 
were met through assistance from the collaborating physician and medical director, and 
the stakeholders of the OI. The preference for management plans, observation, and 
performance indicators would be included by the medical director, as it is ultimately his 
decision whether to implement or not. Finally, the last and ninth objective is that the 
policy should be reviewed yearly. Examination of performance indicators, a discussion 
forum involving risk management professionals and management, and consultation of 
members of the organization should all be a part of the review (Isaac, n.d.). Perhaps the 
subject of a future DNP project could be the review and analysis of the policy 
implementation. 
Policy Writing 
The foundation of any healthcare organization is patient safety. Policies guide 
patient care and are designed to provide better outcomes but only if they are well written. 
Many factors determine the appropriate formulation of a policy—healthcare regulations, 
evidence-based practices, and accreditation standards. The key points in the following 
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paragraph must be considered when writing a policy to guide healthcare providers 
(Heslip, n.d.).  
Policies should be written by those or with the help of those who are experts on 
the topic. A one-size fits all approach to policy writing should be avoided, making sure to 
review existing policies and cross-reference them as needed to prevent a policy from 
contradicting with another. A policy should be original, and not simply a copy and paste 
from a textbook or other literature source. The policy should be written following a 
standardized format and writing style and stored in an easily accessible location. A 
designated location allows those who are searching for the policy to know exactly where 
they need to look for the correct information. After completion of the policy, it should be 
reviewed by an expert in regulatory matters, and ideally someone with experience in 
patient safety. Lastly, the policy writing should involve staff who will be following the 
policy. A consultant or member of a policy and procedure committee can represent the 
staff during the initial phases of policy development and implementation (Heslip, n.d.). 
Summary 
The goal of the project was to create an evidence-based policy as a resource for 
the target population of CRNAs at the OI. The policy could potentially improve 
perioperative pain in patients undergoing instrumented spinal surgery, the other 
population involved in the project. The design included collaboration with the medical 
director of the OI in constructing the policy while utilizing the latest research. 
Throughout the course of the project, potential barriers and ethical issues were carefully 
considered, as were the components of a quality policy and the keys to effective policy 
writing. 
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CHAPTER III – RESULTS 
Recent evidence, recommendations from the manufacturer of dexmedetomidine, 
and input from the medical director of the OI were utilized in the creation of the policy 
for this project. The policy was presented to a panel of experts, which included six 
CRNAs who currently practice at the OI. The participants were chosen because of their 
active involvement in the anesthetic care of patients undergoing spinal surgery. The 
inclusion of these panel members was also influenced by the fact that they would likely 
have been able to provide beneficial feedback. Information provided included recent 
research related to the dosage, timing, and effects of dexmedetomidine administration. 
The panel was asked to read over the presented policy and complete a 5-question survey 
aimed at gaining feedback.  
The results of the surveys are as follows. All participants reported that the policy 
was user-friendly, clear and concise, and met the needs of the institution. In addition, all 
6 participants reported that the policy would help them utilize dexmedetomidine 
effectively. One participant answered “No” when questioned if they would consider 
changing their current practice. Beneath the answer, the respondent indicated that they 
were already utilizing dexmedetomidine intraoperatively during spinal surgery. The 
presentation validated this participant’s current practice and was considered positive 
feedback. The rest of the respondents answered “Yes” to the question and indicated that 
they would consider changing their practice based on the information provided. No 
additional comments or suggestions were presented. 
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Summary 
The panel of experts agreed that the policy was clearly and concisely worded, was 
user-friendly, and met the needs of their institution. The panel also unanimously believed 
that the policy enabled them to utilize dexmedetomidine effectively. Those who were not 
already doing so said they would consider changing their practice to include 
intraoperative dexmedetomidine in the anesthetic care of patients undergoing multilevel 
instrumented spinal surgery. 
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CHAPTER IV – DISCUSSION 
Summary 
The purpose of this project was to gather evidence that supported the use of 
dexmedetomidine during spinal surgery and use that evidence to develop a policy, in 
hopes to implement a practice change. The trending increase in our nation’s opioid 
consumption was the inspiration for this project, but the benefits of dexmedetomidine use 
go far beyond a reduction in narcotic administration. The evidence presented in this 
project and to the panel of experts showed that intraoperative dexmedetomidine 
administration reduced the requirement of other anesthetic agents and opioid 
consumption, decreased PONV and shivering, maintained hemodynamic stability, 
reduced sympathetic responses to intubation, avoided significant respiratory compromise, 
increased patient satisfaction scores, and led to earlier tracheal extubation and recovery 
times. This evidence-based research was the foundation of the policy. The policy was 
developed and written based on Friedman’s Policy Development Framework, the 
recommendations on policy writing, and the components of a quality policy that were 
outlined in Chapter II. 
Interpretation 
Based on the results of the survey, this project was successful in eliciting a 
pathway to practice change. All members of the panel provided positive feedback to the 
effects of dexmedetomidine and the rationale for its use in spinal surgery. In addition, all 
members of the panel were satisfied with the way in which the policy was written and 
worded. Due to the absence of suggestions in the surveys collected, no indications for 
policy revision were present. The decision as to whether the policy was to be 
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implemented or not was left up to the director of the OI. One of the potential barriers to 
this project was the provider’s having a resistance to change. Any such resistance did not 
exist based on the findings. 
Limitations and Future Implications 
The sample size of the expert panel was one limitation for this project. The OI is a 
small facility with 6 operating rooms, and therefore, they do not have many CRNAs there 
day in and day out. Developing a similar policy for a larger facility may have a greater 
impact on the practice of anesthesia, as it would reach more providers. Still, it is possible 
for a small change to kick-start a much larger movement. Perhaps a future DNP project 
can be constructing a similar policy for larger/additional institutions. Another limitation 
was the cost of dexmedetomidine. The added cost of adding the drug to the anesthetic 
plan of all spinal surgeries would make it difficult for the OI to justify the 
implementation of the policy. Another future DNP project could be based on a cost-
analysis of the policy’s implementation. The implementation of the policy itself could 
also be considered a limitation. To remain concise and focus on proper policy creation, 
the decision was made to exclude the implementation process within this project. A 
prospective DNP student may choose to investigate the policy implementation process as 
a topic moving forward. 
Conclusions 
The number of patients undergoing spinal surgery, a painful and stimulating 
procedure typically associated with heavy opioid use both intraoperatively and 
postoperatively, has increased over the last ten years with no signs of slowing down. 
Combine the increase in spinal surgery procedures with the rampant opioid crisis 
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currently affecting our country, and it poses a significant problem that will require 
intervention. This situation presents a prime opportunity to make an impact, by 
implementing practice change among anesthesia providers. The utilization of the various 
multimodal non-narcotic agents, such as dexmedetomidine, is a great place to start in the 
fight against the epidemic. This project, as well as similar ones done in the future, can 
encourage an increase in these adjuncts and a decrease in opioid use. Hopefully, this 
project can assist in advancing the opioid-free movement among anesthesia providers, or 
at the very least, allow for a reduction in the reliance on narcotics. 
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